Literature DB >> 14684871

Tyrosinase expression during neuroblast divisions affects later pathfinding by retinal ganglion cells.

Carolyn A Cronin1, Amy B Ryan, Edmund M Talley, Heidi Scrable.   

Abstract

Occulocutaneous albinism is caused by mutations in the gene encoding the enzyme tyrosinase. Individuals with this disorder are predisposed to visual system deficits. We determined the critical period during development when tyrosinase expression is essential for the appropriate pathfinding of ganglion cell axons from the retina to the dorsal lateral geniculate nucleus. We used a line of mice with a Tyrosinase transgene, the expression of which is regulatable with the lac operator-repressor system, to restrict tyrosinase activity to discrete periods of embryogenesis. When tyrosinase was expressed throughout the period of neuroblast divisions that produce the ipsilaterally projecting ganglion cells, axonal projections innervated the same volume of the ipsilateral dorsal lateral geniculate nucleus of the thalamus as in normal mice. If tyrosinase expression ceased before the end of neuroblast divisions, or was not initiated until after they had begun, the degree of ipsilateral innervation was smaller, as in albino mice. Tyrosinase expression was not required during the entire period of pathfinding itself or during final maturation of the retinogeniculate pathway. Thus, tyrosinase appears to set up a signal early in visual system development that determines the pathway taken later by ganglion cell axons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684871      PMCID: PMC6740940     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

Review 1.  Vertebrate neural cell-fate determination: lessons from the retina.

Authors:  F J Livesey; C L Cepko
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

2.  Genetic control of retinal ganglion cell projections.

Authors:  J H LaVail; R A Nixon; R L Sidman
Journal:  J Comp Neurol       Date:  1978-12-01       Impact factor: 3.215

3.  Abnormal visual pathways in the brain of a human albino.

Authors:  R W Guillery; A N Okoro; C J Witkop
Journal:  Brain Res       Date:  1975-10-17       Impact factor: 3.252

4.  Retinal cell addition and rod production depend on early stages of ocular melanin synthesis.

Authors:  M Ilia; G Jeffery
Journal:  J Comp Neurol       Date:  2000-05-15       Impact factor: 3.215

5.  The lac operator-repressor system is functional in the mouse.

Authors:  C A Cronin; W Gluba; H Scrable
Journal:  Genes Dev       Date:  2001-06-15       Impact factor: 11.361

Review 6.  Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism.

Authors:  W S Oetting; R A King
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

7.  Retinal mitosis is regulated by dopa, a melanin precursor that may influence the time at which cells exit the cell cycle: analysis of patterns of cell production in pigmented and albino retinae.

Authors:  M Ilia; G Jeffery
Journal:  J Comp Neurol       Date:  1999-03-15       Impact factor: 3.215

8.  Slit inhibition of retinal axon growth and its role in retinal axon pathfinding and innervation patterns in the diencephalon.

Authors:  T Ringstedt; J E Braisted; K Brose; T Kidd; C Goodman; M Tessier-Lavigne; D D O'Leary
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

9.  Retinal ganglion cell axon guidance in the mouse optic chiasm: expression and function of robos and slits.

Authors:  L Erskine; S E Williams; K Brose; T Kidd; R A Rachel; C S Goodman; M Tessier-Lavigne; C A Mason
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

10.  Slit2 is a repellent for retinal ganglion cell axons.

Authors:  S P Niclou; L Jia; J A Raper
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

View more
  9 in total

Review 1.  Conversations with Ray Guillery on albinism: linking Siamese cat visual pathway connectivity to mouse retinal development.

Authors:  Carol Mason; Ray Guillery
Journal:  Eur J Neurosci       Date:  2019-04-23       Impact factor: 3.386

Review 2.  Genetically manipulated mice: a powerful tool with unsuspected caveats.

Authors:  Klaus I Matthaei
Journal:  J Physiol       Date:  2007-05-10       Impact factor: 5.182

3.  Eye-specific projections of retinogeniculate axons are altered in albino mice.

Authors:  Alexandra Rebsam; Punita Bhansali; Carol A Mason
Journal:  J Neurosci       Date:  2012-04-04       Impact factor: 6.167

4.  The retinal pigment epithelium undergoes massive apoptosis during early differentiation and pigmentation of the optic cup.

Authors:  M O Pequignot; A C Provost; S Sallé; M Menasche; S Saule; J-P Jaïs; M Abitbol
Journal:  Mol Vis       Date:  2011-04-20       Impact factor: 2.367

5.  Albinism: particular attention to the ocular motor system.

Authors:  Richard W Hertle
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jul-Sep

6.  Regulation of endothelial-specific transgene expression by the LacI repressor protein in vivo.

Authors:  Susan K Morton; Daniel J Chaston; Brett K Baillie; Caryl E Hill; Klaus I Matthaei
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

7.  Asymmetric parental genome engineering by Cas9 during mouse meiotic exit.

Authors:  Toru Suzuki; Maki Asami; Anthony C F Perry
Journal:  Sci Rep       Date:  2014-12-23       Impact factor: 4.379

8.  L-Dopa and the albino riddle: content of L-Dopa in the developing retina of pigmented and albino mice.

Authors:  Suzanne Roffler-Tarlov; Jin Hong Liu; Elena N Naumova; Maria Margarita Bernal-Ayala; Carol A Mason
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  Activation of Wnt signaling reduces ipsilaterally projecting retinal ganglion cells in pigmented retina.

Authors:  Lena Iwai-Takekoshi; Revathi Balasubramanian; Austen Sitko; Rehnuma Khan; Samuel Weinreb; Kiera Robinson; Carol Mason
Journal:  Development       Date:  2018-11-02       Impact factor: 6.862

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.